A randomised controlled trial of low-dose ketamine in youth with severe depression and elevated suicide risk [ 2018 - ]

Research Grant

Researchers: A/Pr Christopher Davey (Principal investigator) ,  A/Pr Benjamin Harrison ,  Dr Donel Martin ,  Prof Andrew Somogyi ,  Prof Bernhard Baune
View all 10 related researchers

Brief description Recent research has shown that a single injection of low-dose ketamine has powerful, though short-lived, antidepressant effects. Effective treatments are urgently needed for young people with severe depression. This will be the first controlled study to test whether repeated doses of ketamine, given over 4 weeks, is effective for young patients.

Funding Amount $2,232,757.00

Funding Scheme Project Grants

Notes Standard Project Grant